Advertisement
YOU ARE HERE: LAT HomeCollectionsUpsa Group
IN THE NEWS

Upsa Group

FEATURED ARTICLES
BUSINESS
September 1, 1990 | From Associated Press
Moving to broaden its business base in Europe, Bristol-Myers Squibb Co. has entered agreements to acquire a minority stake in UPSA Group and to develop the French company's non-prescription drug operations worldwide, the companies announced Friday. Bristol-Myers Squibb would have the opportunity to acquire the remaining shares of UPSA over the longer term under the agreements. Initially, an investment of an undisclosed amount of cash will give Bristol-Myers Squibb 33.56% of UPSA.
ARTICLES BY DATE
BUSINESS
September 8, 1994 | From Times Staff and Wire Reports
EC to Allow Squibb to Buy French Firm: The European Commission said it will allow U.S. pharmaceuticals firm Bristol Myers Squibb Co. to buy the 55% of French pharmaceuticals firm UPSA that it doesn't already own. The commission, the executive body responsible for ensuring open competition in the 12-nation European Union, said the merger will not lead to Squibb gaining a dominant position in the medicines market.
Advertisement
BUSINESS
September 8, 1994 | From Times Staff and Wire Reports
EC to Allow Squibb to Buy French Firm: The European Commission said it will allow U.S. pharmaceuticals firm Bristol Myers Squibb Co. to buy the 55% of French pharmaceuticals firm UPSA that it doesn't already own. The commission, the executive body responsible for ensuring open competition in the 12-nation European Union, said the merger will not lead to Squibb gaining a dominant position in the medicines market.
BUSINESS
September 1, 1990 | From Associated Press
Moving to broaden its business base in Europe, Bristol-Myers Squibb Co. has entered agreements to acquire a minority stake in UPSA Group and to develop the French company's non-prescription drug operations worldwide, the companies announced Friday. Bristol-Myers Squibb would have the opportunity to acquire the remaining shares of UPSA over the longer term under the agreements. Initially, an investment of an undisclosed amount of cash will give Bristol-Myers Squibb 33.56% of UPSA.
Los Angeles Times Articles
|